Prostate cancer biomarkers: from early diagnosis to precision treatment
V Dahiya, S Hans, R Kumari, G Bagchi - Clinical and Translational …, 2024 - Springer
Prostate cancer (PCa) is the second most prevalent cancer in men. In 2020, approximately
1,414,259 new cases were reported that accounted for 3, 75,324 deaths (Sung et al. in CA …
1,414,259 new cases were reported that accounted for 3, 75,324 deaths (Sung et al. in CA …
Prostate cancer biomarkers: from early diagnosis to precision treatment.
V Dahiya, S Hans, R Kumari… - Clinical & Translational …, 2024 - europepmc.org
Prostate cancer (PCa) is the second most prevalent cancer in men. In 2020, approximately
1,414,259 new cases were reported that accounted for 3, 75,324 deaths (Sung et al. in CA …
1,414,259 new cases were reported that accounted for 3, 75,324 deaths (Sung et al. in CA …
Prostate cancer biomarkers: from early diagnosis to precision treatment
V Dahiya, S Hans, R Kumari… - Clinical & translational … - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is the second most prevalent cancer in men. In 2020, approximately
1,414,259 new cases were reported that accounted for 3, 75,324 deaths (Sung et al. in CA …
1,414,259 new cases were reported that accounted for 3, 75,324 deaths (Sung et al. in CA …